Article ID Journal Published Year Pages File Type
2404006 Vaccine 2011 6 Pages PDF
Abstract

IntroductionIXIARO (IC51), a recently approved inactivated Japanese Encephalitis vaccine, is immunogenic and safe in a 0/28 days primary immunization schedule. Neutralizing antibody titers decline with time and booster doses are likely needed to enhance persistence of immunity.ObjectivesTo assess the effect of a booster dose on neutralizing JE antibody titers for up to 12 months after boostering.MethodsIn this phase III trial, 198 subjects, who had received primary immunization in a preceding randomized trial, were boosted with IXIARO 15 months after the primary immunization. Neutralizing antibody titers were assessed by plaque-reduction neutralisation test, PRNT.ResultsPrior to the booster dose, 69.2% (137/198) of subjects had PRNT50 titers ≥1:10. One month after the booster, the rate of subjects with PRNT50 ≥ 1:10 (recognized as a protective titer) was 100%. This rate remained high at 98.5% at 6 and 12 months; GMTs were 22.5 before the booster and 900, 487 and 361 at 1, 6 and 12 months after the booster, respectively.ConclusionA booster dose of IXIARO at 15 months after primary immunization was highly immunogenic with GMTs >5-fold higher than those seen immediately after primary immunization, and remained at high levels for at least 12 months after the booster. NCT00595309.

Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , , , , , , , , , ,